Project measures / variables set:   GMC16   amylase

ID, description, units MPD:56534   amylase   alpha-amylase (plasma)   [IU/L]  
Measures • age 16-17wks    • 20-21wks
Data set, strains GMC16   inbred w/CC8   8 strains     sex: both
Procedure metabolic panel
Comparisonmultiple cohorts measured at two age timepoints
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

GMC16 - alpha-amylase (plasma)





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
age 1 802099.8295 802099.8295 73.9149 < 0.0001
sex 1 216520.9011 216520.9011 19.9528 < 0.0001
strain 4 2212667.2541 553166.8135 50.9753 < 0.0001
age:sex 1 835.071 835.071 0.077 0.7819
age:strain 4 82881.7457 20720.4364 1.9094 0.1128
sex:strain 4 239165.6159 59791.404 5.5099 0.0004
age:sex:strain 4 80786.9712 20196.7428 1.8612 0.1212
Residuals 128 1389012.3825 10851.6592

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
GMC16 56534 metabolic panel (none) alpha-amylase (plasma)   [IU/L]   at age 16-17wks  amylase_17 inbred w/CC8 7 both 16-17wks
GMC16 56535 metabolic panel (none) alpha-amylase (plasma)   [IU/L]   at age 20-21wks  amylase_21 inbred w/CC8 8 both 20-21wks